Ertapenem Injectable (iv/im) Generics - Manufacturers & Suppliers
Invanz(US & EU)
| Product/Composition:- | Ertapenem Injectable (IV/IM) |
|---|---|
| Strength:- | 1 g per vial for IV or IM use |
| Form:- | Injectable (IV/IM) |
| Reference Brands:- | Invanz(US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Ertapenem inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis and death. Its broad-spectrum activity includes resistant gram-negative bacteria. Benefits include rapid bacterial clearance, high tissue penetration, once-daily dosing, and effectiveness against serious infections like intra-abdominal infections and pneumonia in hospital settings.
Ertapenem injectable is approved in the EU and US for treating complicated intra-abdominal infections, skin and soft tissue infections, and community-acquired pneumonia. In the EU, brands like Invanz are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA-approved formulations are based on extensive clinical data; generic versions are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans, for approval and ongoing safety monitoring. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective antibacterial therapy.